Navigation Links
Gold nanoparticles give an edge in recycling CO2
Date:10/24/2013

PROVIDENCE, R.I. [Brown University] By tuning gold nanoparticles to just the right size, researchers from Brown University have developed a catalyst that selectively converts carbon dioxide (CO2) to carbon monoxide (CO), an active carbon molecule that can be used to make alternative fuels and commodity chemicals.

"Our study shows potential of carefully designed gold nanoparticles to recycle CO2 into useful forms of carbon," said Shouheng Sun, professor of chemistry and one of the study's senior authors. "The work we've done here is preliminary, but we think there's great potential for this technology to be scaled up for commercial applications."

The findings are published in the Journal of the American Chemical Society.

The idea of recycling CO2 a greenhouse gas the planet current has in excess is enticing, but there are obstacles. CO2 is an extremely stable molecule that must be reduced to an active form like CO to make it useful. CO is used to make synthetic natural gas, methanol, and other alternative fuels.

Converting CO2 to CO isn't easy. Prior research has shown that catalysts made of gold foil are active for this conversion, but they don't do the job efficiently. The gold tends to react both with the CO2 and with the water in which the CO2 is dissolved, creating hydrogen byproduct rather than the desired CO.

The Brown experimental group, led by Sun and Wenlei Zhu, a graduate student in Sun's group, wanted to see if shrinking the gold down to nanoparticles might make it more selective for CO2. They found that the nanoparticles were indeed more selective, but that the exact size of those particles was important. Eight nanometer particles had the best selectivity, achieving a 90-percent rate of conversion from CO2 to CO. Other sizes the team tested four, six, and 10 nanometers didn't perform nearly as well.

"At first, that result was confusing," said Andrew Peterson, professor of engineering and also a senior author on the paper. "As we made the particles smaller we got more activity, but when we went smaller than eight nanometers, we got less activity."

To understand what was happening, Peterson and postdoctoral researcher Ronald Michalsky used a modeling method called density functional theory. They were able to show that the shapes of the particles at different sizes influenced their catalytic properties.

"When you take a sphere and you reduce it to smaller and smaller sizes, you tend to get many more irregular features flat surfaces, edges and corners," Peterson said. "What we were able to figure out is that the most active sites for converting CO2 to CO are the edge sites, while the corner sites predominantly give the by-product, which is hydrogen. So as you shrink these particles down, you'll hit a point where you start to optimize the activity because you have a high number of these edge sites but still a low number of these corner sites. But if you go too small, the edges start to shrink and you're left with just corners."

Now that they understand exactly what part of the catalyst is active, the researchers are working to further optimize the particles. "There's still a lot of room for improvement," Peterson said. "We're working on new particles that maximize these active sites."

The researchers believe these findings could be an important new avenue for recycling CO2 on a commercial scale.

"Because we're using nanoparticles, we're using a lot less gold than in a bulk metal catalyst," Sun said. "That lowers the cost for making such a catalyst and gives the potential to scale up."


'/>"/>

Contact: Kevin Stacey
kevin_stacey@brown.edu
401-863-3766
Brown University
Source:Eurekalert  

Related biology news :

1. Stealth nanoparticles lower drug-resistant tumors defenses
2. Researchers figure out why gold nanoparticles can penetrate cell walls
3. Nanoparticles, pH phoresis could improve cancer drug delivery
4. MU researchers develop radioactive nanoparticles that target cancer cells
5. Trackable drug-filled nanoparticles -- a potential weapon against cancer
6. X-rays reveal uptake of nanoparticles by soya bean crops
7. Achilles heel: Popular drug-carrying nanoparticles get trapped in bloodstream
8. Nanoparticles reach new peaks
9. Study reports iron oxide nanoparticles effective for labeling human endothelial cells
10. Synthetic and biological nanoparticles combined to produce new metamaterials
11. UC Davis researchers develop new drug delivery system for bladder cancer using nanoparticles
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gold nanoparticles give an edge in recycling CO2
(Date:12/2/2016)... , December 1, 2016 ... (Fingerprint, Voice), Future Technology (Iris Recognition System), Vehicle ... - Global Forecast to 2021", published by MarketsandMarkets, ... Million in 2016, and is projected to grow ... CAGR of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... 2016 Not many of us realize that we spend ? of our ... need to do it well. Inadequate sleep levels have been found to lead to ... and even cancer. Maybe now is the best time to rethink how ... to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... BioDirection, a privately held medical device company ... detection of concussion and other traumatic brain injury (TBI), ... meeting with the U.S. Food and Drug Administration (FDA) ... During the meeting company representatives reviewed plans for clinical ... commencement of a planned pilot trial. ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... ... for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. ... media products engineered to radically streamline culture processes, minimize processing time, significantly ...
(Date:12/8/2016)... 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a ... plans to commercialize innovative therapeutics for patients with ... were approved for trading on the OTCQX U.S. ... OTCQX, effective today, under the ticker symbol "HPPI." ... companies must meet high financial standards, follow best ...
(Date:12/7/2016)... ... 07, 2016 , ... ACEA Biosciences, Inc. presented today updated ... trial for its lead drug candidate, AC0010, at the World Conference on Lung ... determine the safety, antitumor activity, and recommended phase II dosage of AC0010 in ...
(Date:12/7/2016)... 7, 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") ... presented at the Company,s Annual and Special Meeting. ... take place on Thursday, December 15, 2016 at ... (Room EC1040), 4825 Mount Royal Gate SW, Calgary, ... of meeting and management information circular, containing the matters to ...
Breaking Biology Technology: